Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07290309
What this trial is testing

Survivors Uniting for Remote Guided Exercise

Who this might be right for
CancerCancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)Physical Activity+4 more
Colorado State University 300
Early research (Phase 1)Looking for participantsNCT05283330
What this trial is testing

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Who this might be right for
Cervical CancerBreast CancerColon Cancer+4 more
Orano Med Theranostics, SAS 48
Not applicableStudy completedNCT06713681
What this trial is testing

Trop2-targeting NIR-II Molecular Probe for Breast Cancer Precise Surgery

Who this might be right for
Breast CancerSentinel Lymph NodeMargins of Excision
Yunnan Cancer Hospital 59
Not applicableStudy completedNCT01943500
What this trial is testing

Collection of Blood Specimens for Circulating Tumor Cell Analysis

Who this might be right for
Breast CancerProstate CancerColorectal Cancer
Viatar LLC 14
Early research (Phase 1)Study completedNCT00426530
What this trial is testing

Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Study completedNCT02129556
What this trial is testing

Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer

Who this might be right for
Metastatic Breast Cancer
ETOP IBCSG Partners Foundation 58
Not applicableStudy completedNCT03280719
What this trial is testing

Whole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 Fractions

Who this might be right for
Breast NeoplasmsRadiotherapyLymph Node Metastases
University Hospital, Ghent 61
Testing effectiveness (Phase 2)Looking for participantsNCT06543992
What this trial is testing

Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Methotrexate in Breast Cancer With Leptomeningeal Metastasis

Who this might be right for
Leptomeningeal Metastasis of Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 22
Not applicableLooking for participantsNCT07542496
What this trial is testing

Real-world Bicohort Observational Study of a Pertuzumab Biosimilar in the Treatment of Breast Cancer: in the Neoadjuvant Setting and in First-line Metastatic Disease

Who this might be right for
Breast CancerHer 2 Positive Breast Cancer
Société Algérienne de Formation et Recherche en Oncologie 1,000
Early research (Phase 1)Active Not RecruitingNCT03821935
What this trial is testing

Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 364
Testing effectiveness (Phase 2)UnknownNCT03412955
What this trial is testing

A Pilot Study of Eribulin in Breast Cancer (BC) Patients With Brain Metastases Previously Treated With Anthracyclines and Taxanes

Who this might be right for
Breast Cancer
Tan Tock Seng Hospital 14
Testing effectiveness (Phase 2)Ended earlyNCT01953926
What this trial is testing

Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations

Who this might be right for
Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations
Puma Biotechnology, Inc. 582
Testing effectiveness (Phase 2)Looking for participantsNCT05535413
What this trial is testing

UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases

Who this might be right for
Metastatic HER2 Negative Breast CarcinomaBrain MetastasesCapecitabine+1 more
Hunan Cancer Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00566618
What this trial is testing

Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis

Who this might be right for
Breast CancerBone Metastases
M.D. Anderson Cancer Center 31
Not applicableLooking for participantsNCT06144346
What this trial is testing

Metastases Directed Therapy for Oligometastatic Breast Cancer

Who this might be right for
Breast CancerMetastatic CancerMetastatic Breast Cancer
National Cancer Institute, Egypt 150
Testing effectiveness (Phase 2)Looking for participantsNCT05735080
What this trial is testing

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Who this might be right for
Breast CancerBreast Cancer MetastaticHormone Receptor Positive Tumor+6 more
Incyclix Bio 150
Early research (Phase 1)Looking for participantsNCT06545942
What this trial is testing

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorProstate Cancer+4 more
MOMA Therapeutics 220
Early research (Phase 1)Ended earlyNCT02122146
What this trial is testing

PF-06664178 In Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Pfizer 31
Not applicableUnknownNCT05633680
What this trial is testing

Circulating Tumor Cells Screen for Breast Cancer

Who this might be right for
Breast NeoplasmNeoplastic Cells, Circulating
Handan First Hospital 200
Large-scale testing (Phase 3)Looking for participantsNCT03418961
What this trial is testing

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Who this might be right for
CardiotoxicityHER2/Neu PositiveMetastatic Malignant Neoplasm in the Brain+2 more
SWOG Cancer Research Network 491
Next Page